Bispecific antibody therapy is transforming cancer treatment, especially in multiple myeloma, with ongoing studies exploring ...

Canada lags behind other developed countries when it comes to the length of time it takes to approve desperately needed ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that forms in plasma cells, a white ...

At just 42 years old, Allison Freedman's life took an unexpected and devastating turn. She was a busy mom raising ...

A SINGLE mum’s suspected diabetes symptoms turned out to be incurable cancer. Jodie Hill, 46, was told she had three months ...

Don Wright of Stillwater, a retired engineer, lawyer, and father of three, ran his first marathon in 2003, at the age of 61.

The therapy is a critical treatment option for various life-threatening disease. Earlier, GST on gene therapy was set at 12 ...

Legend Biotech Corporation (NASDAQ:LEGN) is a clinical-stage company that develops, discovers, manufactures, and ...

As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion ...

Panelists discuss how the CEPHEUS trial demonstrates the comparative efficacy and safety of subcutaneous daratumumab combined with VRd vs VRd alone in patients with transplant-ineligible or transplant ...

Research analysts at StockNews.com initiated coverage on shares of Cellectis (NASDAQ:CLLS – Get Free Report) in a report released on Thursday. The brokerage set a “sell” rating on the biotechnology ...